Balancing Innovation with Risk and Regulation to Drive Sustained Performance
BIO’s preferred partner Chubb has compiled a special report on life sciences in the middle market titled: Balancing Innovation with Risk and Regulation to Drive Sustained Performance. This report presents key findings that can serve as a platform for middle market life sciences executives looking for insight into their own challenges as well as the challenges faced by their partners in the industry. It provides valuable information for regulators and economic development agencies who are, perhaps more keenly than ever, invested in the ongoing growth and vitality of this essential segment of the economy. As the industry evolves and new risks emerge, life sciences companies require integrated insurance solutions that can be crafted to meet the needs of each individual business. Industry trends and our own data suggest that a more holistic solution is required.